Positive Health Online
Your Country
Research: FIGUEIREDO and COLLEAGUES,
Listed in Issue 295
Abstract
FIGUEIREDO and COLLEAGUES, 1 Department of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA; 2 Department of Neurology and Program in Neuroscience, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD, 20814, USA; 3 Department of Neurology and Program in Neuroscience, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD, 20814, USA. ann.marini@usuhs.edu studied the effects of cortical impact (CCI) injury in rodents and how treatment with alpha-linolenic acid (ALA) with for CCI prevents neuropathology and pathophysiological effects of mTBI.
Background
Approximately, 1.7 million Americans suffer a Traumatic Brain Injury (TBI) annually and TBI is a major cause of death and disability.
Methodology
The majority of the TBI cases are of the mild type and while most patients recover completely from mild TBI (mTBI) about 10% result in persistent symptoms and some result in lifelong disability. Anxiety disorders are the second most common diagnosis post-TBI. Of note, TBI-induced anxiety disorders are difficult to treat and remain a chronic condition suggesting that new therapies are needed.
Results
Previous work from our laboratory demonstrated that a mild TBI induced an anxiety-like phenotype, a key feature of the human condition, associated with loss of GABAergic interneurons and hyper excitability in the basolateral amygdala (BLA) in rodents 7 and 30 days after a controlled cortical impact (CCI) injury. We now confirm that animals display significantly increased anxiety-like behavior 30 days after CCI. The anxiety-like behavior was associated with a significant loss of GABAergic interneurons and significant reductions in the frequency and amplitude of spontaneous and miniature GABAA-receptor-mediated inhibitory postsynaptic currents (IPSCs) in the BLA. Significantly, sub chronic treatment with alpha-linolenic acid (ALA) after CCI prevents the development of anxiety-like behaviour, the loss of GABAergic interneurons, hyper excitability in the BLA and reduces the impact injury.
Conclusion
Taken together, administration of ALA after CCI is a potent therapy against the neuropathology and pathophysiological effects of mTBI in the BLA.
References
Taiza H Figueiredo 1 , Carolina L Harbert 1 , Volodymyr Pidoplichko 1 , Camila P Almeida-Suhett 1 , Hongna Pan 2 , Katia Rossetti 1 , Maria F M Braga 1 , Ann M Marini 3. Alpha-Linolenic Acid Treatment Reduces the Contusion and Prevents the Development of Anxiety-Like Behavior Induced by a Mild Traumatic Brain Injury in Rats Mol Neurobiol;55(1):187-200. doi: 10.1007/s12035-017-0732-y. Jan 2018.